More than 250 million Africans rely on the starchy root crop cassava (Manihot esculenta) as their staple source of calories. A typical cassava-based diet, however, provides less than 30% of the minimum daily requirement for protein and only 10%–20% of that for iron, zinc, and vitamin A. The BioCassava Plus (BC+) program has employed modern biotechnologies intended to improve the health of Africans through the development and delivery of genetically engineered cassava with increased nutrient (zinc, iron, protein, and vitamin A) levels.

Various indications that research and development efforts are escalating in developing countries indicate the slight shift of such countries from just being end markets to being developers. The aggregate adoption of biotech crops in developing countries is clearly approaching that in developed countries. The next generation biotech crops with superior traits, with improved properties and quality traits will likely be created and deployed in developing countries, particularly in Asia, where half of the world’s population dwells.

This is an internal document for the phase I of CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS). The phase II capacity development strategy can be found here: https://hdl.handle.net/10568/82591. Capacity enhancement is a central priority for CCAFS.